Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer
cells, either by killing the cells or by stopping them from dividing. It is not yet known
which combination chemotherapy regimen is more effective in treating young patients with
acute lymphoblastic leukemia.
PURPOSE: This partially randomized phase III trial is studying how well combination
chemotherapy works in treating young patients with relapsed or refractory acute lymphoblastic
leukemia.